Clinical Trial Update: Bevacizumab and Temozolomide Following Radiation and Chemotherapy for Newly Diagnosed Glioblastoma Multiforme [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating bevacizumab with temozolomide after radiation/chemotherapy in newly diagnosed glioblastoma multiforme has completed with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Drugs mentioned

• Bevacizumab (bevacizumab)
• Temozolomide (Temozolomide)

Snippet

Sponsor: University of Chicago | Conditions: Glioblastoma Multiforme | Phase 2 | Status: COMPLETED | Results posted: 2021-03-01